Cargando…
DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties
Development of novel bioactive compounds against KRAS and/or BRAF mutant colorectal cancer (CRC) is currently an urgent need in oncology. In addition, single or multitarget kinase inhibitors against MEK/ERK and PI3K/AKT pathways are of potential therapeutic advantage. A new compound based on the ben...
Autores principales: | Goulielmaki, Maria, Assimomytis, Nikos, Rozanc, Jan, Taki, Eleni, Christodoulou, Ioannis, Alexopoulos, Leonidas G., Zoumpourlis, Vassilis, Pintzas, Alexandros, Papahatjis, Demetris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520640/ https://www.ncbi.nlm.nih.gov/pubmed/31096110 http://dx.doi.org/10.1016/j.tranon.2019.04.005 |
Ejemplares similares
-
Oil-In-Water Microemulsions as Hosts for Benzothiophene-Based Cytotoxic Compounds: An Effective Combination
por: Theochari, Ioanna, et al.
Publicado: (2018) -
Addendum: Oil-In-Water Microemulsions as Hosts for Benzothiophene-Based Cytotoxic Compounds: An Effective Combination. Biomimetics 2018, 3, 13
por: Theochari, Ioanna, et al.
Publicado: (2018) -
Suitability of Human Mesenchymal Stem Cells Derived from Fetal Umbilical Cord (Wharton’s Jelly) as an Alternative In Vitro Model for Acute Drug Toxicity Screening
por: Christodoulou, Ioannis, et al.
Publicado: (2022) -
miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and Therapy
por: Thomaidou, Arsinoe C., et al.
Publicado: (2023) -
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
por: Christodoulou, Ioannis, et al.
Publicado: (2018)